Right Ventricular Contractile Reserve in HF

NCT ID: NCT05797584

Last Updated: 2023-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-20

Study Completion Date

2026-03-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Right ventricle dysfunction and pulmonary hypertension are related to a worse prognosis in patients with heart failure with reduced left ventricular ejection fraction (HFrEF) or with normal left ventricular ejection fraction (HFpEF).

There is preliminary evidence however, that the responses of the right ventricle and of the pulmonary hemodynamics to stress tests (especially physical stress) may allow to prognostically stratify these patients, as these responses may bring out latent right ventricle dysfunction or a normal contractile reserve in patients with dysfunction at rest.

In view of the different pathophysiological mechanisms of the left ventricular dysfunction in HFpEF and in HFrEF, also the response and the adaptation of the righty ventricle to stress tests may be different in these two groups of patients.

In this preliminary two groups of 20 patients with HFpEF and HFrEF will be subjected to to simple stress tests: passive leg raising and inotropic stimulus with dobutamine.

This study intends to analyze, through colorDoppler echocardiography, the behaviour of the right ventricle and the pulmonary circulation during passive leg raining and infusion of dobutamine, in a cohort of patients with HFrEF or HFpEF.

The analysis will be focused on the relation between echocardiographic parameters, especially those concerning right ventricular function and pulmonary hemodynamics, thereby comparing the responses observed in HFrEF vs HFpEF.

Furthermore, correlations between the above-mentioned echocardiographic parameters and parameters of daily clinical practice will be assessed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EchocardiocolorDoppler

EchocardiocolorDoppler examination

Group Type OTHER

Dobutamine

Intervention Type DRUG

Dobutamine 5.0 - 10.0 mcg/Kg/min ev

Passive leg raising

Intervention Type OTHER

Passive leg raising for acute volume load

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dobutamine

Dobutamine 5.0 - 10.0 mcg/Kg/min ev

Intervention Type DRUG

Passive leg raising

Passive leg raising for acute volume load

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* heart failure with reduced (EF ≤40%) or preserved (EF \> 50%) ejection fraction
* echocardiographic acoustic window adequate for evaluation of outcome parameters
* presence of tricuspid insufficiency which allows assessment of pulmonary artery systolic pressure

Exclusion Criteria

* recent myocardial infraction (\<3 months) or unstable angina
* moderate o severe aortic or mitralic valve disease
* inadequate acoustic window
* significant anemia (hemoglobin \<10 g/dl)
* recent heart surgery (\< 3 months).
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istituto Auxologico Italiano

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ospedale San Luca IRCCS Istituto Auxologico Italiano

Milan, MI, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sergio Caravita, MD, PhD

Role: CONTACT

+390261911 ext. 2930

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sergio Caravita, MD, PhD

Role: primary

+390261911 ext. 2930

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

09C923

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.